After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials

Xconomy ONL Therapeutics, the Ann Arbor, MI-based biotech startup working on sight-preserving therapies for patients with retinal diseases, is one step closer to clinical trials, thanks to a cash infusion from the National Eye Institute (NEI)….

Read the Article

Privacy Statement | Accessibility Statement | Terms of Use | Copyright All Rights Reserved ©2024